Beyond Batten Disease Foundation
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2008-01-01
- Employees
- -
- Market Cap
- -
- Website
- http://www.beyondbatten.org
An Open-label Safety, Pharmacokinetic, and Efficacy Study of Miglustat for the Treatment of CLN3 Disease
- First Posted Date
- 2021-12-30
- Last Posted Date
- 2025-06-13
- Lead Sponsor
- Beyond Batten Disease Foundation
- Target Recruit Count
- 6
- Registration Number
- NCT05174039
- Locations
- 🇺🇸
Texas Children Hospital, Houston, Texas, United States